Computer Vision Algorithms and Skin Cancer Detection

The presentation discusses the application of computer vision algorithms, particularly convolutional neural networks, in skin cancer detection. It highlights the challenges and vulnerabilities these algorithms face when applied outside controlled settings, revealing a significant discrepancy between their performance in laboratory environments and real-world clinical practice. Studies from respected institutions, like Memorial Sloan Kettering, indicate that many algorithms underperform, especially when diagnosing non-represented conditions, leading to high rates of false positives. A research project involving over 1,000 lesions showed disappointing sensitivity rates, with some algorithms displaying sensitivity as low as 28% for skin cancer detection. Moreover, algorithm performance is adversely affected by variations in skin tone, showcasing a lack of adequate representation in training datasets for diverse populations, which raises concerns about their applicability in clinics serving those groups. The discussion also covers the real-world deployment of an algorithm in the UK's NHS to triage referrals, emphasizing the importance of safety and predictive value; however, it notes issues like missed melanomas. Additionally, promising results were seen in another study where AI augmented dermatologist capabilities, although vulnerabilities remain if algorithms are applied beyond their intended scope. In conclusion, while there are encouraging signs for the use of AI in dermatology, careful validation and transparency regarding algorithm training data relevance are essential to ensure safety and effectiveness.